The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Coronary Restenosis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Coronary Restenosis


High impact information on Coronary Restenosis


Chemical compound and disease context of Coronary Restenosis


Biological context of Coronary Restenosis


Anatomical context of Coronary Restenosis


Gene context of Coronary Restenosis


Analytical, diagnostic and therapeutic context of Coronary Restenosis


  1. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Speir, E., Modali, R., Huang, E.S., Leon, M.B., Shawl, F., Finkel, T., Epstein, S.E. Science (1994) [Pubmed]
  2. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Munro, E., Patel, M., Chan, P., Betteridge, L., Clunn, G., Gallagher, K., Hughes, A., Schachter, M., Wolfe, J., Sever, P. Eur. J. Clin. Invest. (1994) [Pubmed]
  3. Homocysteine and post-angioplasty restenosis. Ambrosi, P. Nutrition, metabolism, and cardiovascular diseases : NMCD. (2003) [Pubmed]
  4. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F.R., Meier, B., Turi, Z.G., Hess, O.M. N. Engl. J. Med. (2001) [Pubmed]
  5. Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty. Panda, D., Kundu, G.C., Lee, B.I., Peri, A., Fohl, D., Chackalaparampil, I., Mukherjee, B.B., Li, X.D., Mukherjee, D.C., Seides, S., Rosenberg, J., Stark, K., Mukherjee, A.B. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  6. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo. Chen, S.J., Chen, Y.F., Miller, D.M., Li, H., Oparil, S. Circulation (1994) [Pubmed]
  7. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Biro, S., Fu, Y.M., Yu, Z.X., Epstein, S.E. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  8. Plasminogen activator inhibitor-1 plasma levels and coronary restenosis. Huber, K., Binder, B.R. Circulation (1992) [Pubmed]
  9. Predicting late restenosis after coronary angioplasty by very early (12 to 24 h) thallium-201 scintigraphy: implications with regard to mechanisms of late coronary restenosis. Hardoff, R., Shefer, A., Gips, S., Merdler, A., Flugelman, M.Y., Halon, D.A., Lewis, B.S. J. Am. Coll. Cardiol. (1990) [Pubmed]
  10. Tranilast inhibits contraction and Ca2+ movement of porcine coronary arteries. Ishibashi, S., Ikeda, U., Ihara, T., Shimada, K. Atherosclerosis (1997) [Pubmed]
  11. Clinical results with AGI-1067: a novel antioxidant vascular protectant. Tardif, J.C. Am. J. Cardiol. (2003) [Pubmed]
  12. Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial). Moses, J.W., Moussa, I., Leon, M.B., Teirstein, P.S., Fish, R.D., Ellis, S.G., Nawas, D., Kluck, B., Giorgianni, J.A., Donohoe, D., Kuntz, R.E. Am. J. Cardiol. (2002) [Pubmed]
  13. Costs of coronary restenosis (Lovastatin Restenosis Trial). Gilbert, S.P., Weintraub, W.S., Talley, J.D., Boccuzzi, S.J. Am. J. Cardiol. (1996) [Pubmed]
  14. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. Tsai, H.L., Kou, G.H., Chen, S.C., Wu, C.W., Lin, Y.S. J. Biol. Chem. (1996) [Pubmed]
  15. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. MacLeod, D.C., Strauss, B.H., de Jong, M., Escaned, J., Umans, V.A., van Suylen, R.J., Verkerk, A., de Feyter, P.J., Serruys, P.W. J. Am. Coll. Cardiol. (1994) [Pubmed]
  16. Percutaneous transluminal coronary angioplasty improves oxygen uptake kinetics during the onset of exercise in patients with coronary artery disease. Adachi, H., Koike, A., Niwa, A., Sato, A., Takamoto, T., Marumo, F., Hiroe, M. Chest (2000) [Pubmed]
  17. Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Arefieva, T.I., Provatorov, S.I., Samko, A.N., Krasnikova, T.L., Resink, T.J., Erne, P., Tkachuk, V.A., Chazov, E.I. Clin. Exp. Pharmacol. Physiol. (2001) [Pubmed]
  18. Leukocyte CD15 expression and platelet activation in the coronary sinus after coronary intervention. Rauch, U., Wolff, U.M., Schultheiss, H.P., Schwimmbeck, P.L. Pathophysiol. Haemost. Thromb. (2003) [Pubmed]
  19. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Strauss, B.H., Lau, H.K., Bowman, K.A., Sparkes, J., Chisholm, R.J., Garvey, M.B., Fenkell, L.L., Natarajan, M.K., Singh, I., Teitel, J.M. Circulation (1999) [Pubmed]
  20. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. Heeschen, C., Hamm, C.W., Bruemmer, J., Simoons, M.L. J. Am. Coll. Cardiol. (2000) [Pubmed]
  21. Inhibition of coronary restenosis by antithrombin III in atherosclerotic swine. Ali, M.N., Mazur, W., Kleiman, N.S., Rodgers, G.P., Abukhalil, J.M., French, B.A., Raizner, A.E. Coron. Artery Dis. (1996) [Pubmed]
  22. Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis. Nishikawa, H., Miura, S., Shimomura, H., Tsujita, K., Okamura, K., Zhang, B., Iwata, A., Shirai, K., Matsuo, K., Arai, H., Saku, K. Journal of cardiology. (2005) [Pubmed]
  23. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis. Huber, K., Jörg, M., Probst, P., Schuster, E., Lang, I., Kaindl, F., Binder, B.R. Thromb. Haemost. (1992) [Pubmed]
  24. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model. Kipshidze, N.N., Iversen, P., Kim, H.S., Yiazdi, H., Dangas, G., Seaborn, R., New, G., Tio, F., Waksman, R., Mehran, R., Tsapenko, M., Stone, G.W., Roubin, G.S., Iyer, S., Leon, M.B., Moses, J.W. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. (2004) [Pubmed]
  25. Initial studies with gamma radiotherpay to inhibit coronary restenosis. Teirstein, P.S., Massullo, V., Jani, S., Tripuraneni, P. Cardiovasc. Radiat. Med. (1999) [Pubmed]
WikiGenes - Universities